HAWKEYE BIO
Hawkeye Bio is developing patented nanoscale biosensors (NBS) for disease detection. The company's lead clinical program in oncology is focused on the deployment of nanobiosensors to non-invasively detect early stage cancer. Identifying cancer reliably, safely, and affordably at the earliest stage is critical for successful treatment and survival. The NBS are also being evaluated to monitor patients post-treatment to identify cases of minimal residual disease and intercept recurrence. The NBS platform is also being clinically evaluated for applications in infectious and autoimmune disease.
HAWKEYE BIO
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Torrance, California, United States
Country:
United States
Website Url:
http://www.hawkeyebio.com
Total Employee:
11+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Euro Typekit Squarespace Squarespace Hosted
Founder
Investors List
NJF Capital
NJF Capital investment in Convertible Note - Hawkeye Bio
NJF Capital
NJF Capital investment in Seed Round - Hawkeye Bio
Official Site Inspections
http://www.hawkeyebio.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
